Piershale Financial »

Brainstorm Cell Therapeutics shares owned by Piershale Financial

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Piershale Financial from 13F filings

Historical chart of Piershale Financial investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Piershale Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Piershale Financial

Quarter filed Position value Share count Share price at filing
2023-06-30 $206 100 2.06
2023-03-31 $330 100 3.30